In regard to the alternative OSMR ligand interleukin-31 (IL-31), IL31 transcripts were detected at least 2 orders of magnitude lower compared to OSM transcripts (Figure 1C) and there was no difference in OS between high and low IL31 expressing AML with the 50% cut-off (Figure 1D). This evidence concerns the gene IL31 and acute myeloid leukemia.